Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
14.60
+0.72 (5.19%)
Dec 20, 2024, 4:00 PM EST - Market closed

Inhibrx Biosciences Market Cap

Inhibrx Biosciences has a market cap or net worth of $211.35 million as of December 20, 2024.

Market Cap
211.35M
Enterprise Value
16.85M
1-Year Change
n/a
Ranking
Category
Stock Price
$14.60

Market Cap Chart

Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $211.35M, an increase of 6.61%. That is a compound annual growth rate of 12.08%.

History

DateMarket Cap% Change
Dec 20, 2024211.35M6.61%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
DiaMedica Therapeutics 208.24M
SOPHiA GENETICS 205.96M
ADC Therapeutics 204.98M
Inventiva 202.51M
Lexeo Therapeutics 199.72M
Atai Life Sciences 199.68M
MacroGenics 199.59M
Akso Health Group 198.11M
Market Cap Rankings